Marianne Shawe-Taylor

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

M. Piccart, M. Filetti, R. Salazar, 2022, The Lancet Oncology.

Foundation doctors and quality improvement: frustrations from the frontline

Z. Chaudhry, Marianne Shawe-Taylor, J. Lam, 2019, Postgraduate Medical Journal.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

M. Filetti, R. Salazar, A. Maconi, 2022, European Journal of Cancer.

Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway

J. Kumar, G. Dockray, A. Varró, 2017, Peptides.

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

M. Piccart, M. Filetti, F. Grosso, 2023, The Lancet Oncology.

Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate

B. Williams, M. Marks, H. Esmail, 2021, Journal of Infection.